Literature DB >> 36253810

Autosomal dominant Emery-Dreifuss muscular dystrophy caused by a mutation in the lamin A/C gene identified by exome sequencing: a case report.

Kristy Iskandar1, Farida Niken Astari2, Rizki Amalia Gumilang3, Nissya Ilma4, Ni Putu Shartyanie4, Guritno Adistyawan5, Grace Tan6, Poh San Lai6.   

Abstract

BACKGROUND: Emery-Dreifuss Muscular Dystrophy (EDMD) is an uncommon genetic disease among the group of muscular dystrophies. EDMD is clinically heterogeneous and resembles other muscular dystrophies. Mutation of the lamin A/C (LMNA) gene, which causes EDMD, also causes many other diseases. There is inter and intrafamilial variability in clinical presentations. Precise diagnosis can help in patient surveillance, especially before they present with cardiac problems. Hence, this paper shows how a molecular work-out by next-generation sequencing can help this group of disorders. CASE
PRESENTATION: A 2-year-10-month-old Javanese boy presented to our clinic with weakness in lower limbs and difficulty climbing stairs. The clinical features of the boy were Gower's sign, waddling gait and high CK level. His father presented with elbow contractures and heels, toe walking and weakness of limbs, pelvic, and peroneus muscles. Exome sequencing on this patient detected a pathogenic variant in the LMNA gene (NM_170707: c.C1357T: NP_733821: p.Arg453Trp) that has been reported to cause Autosomal Dominant Emery-Dreifuss muscular dystrophy. Further examination showed total atrioventricular block and atrial fibrillation in the father.
CONCLUSION: EDMD is a rare disabling muscular disease that poses a diagnostic challenge. Family history work-up and thorough neuromuscular physical examinations are needed. Early diagnosis is essential to recognize orthopaedic and cardiac complications, improving the clinical management and prognosis of the disease. Exome sequencing could successfully determine pathogenic variants to provide a conclusive diagnosis.
© 2022. The Author(s).

Entities:  

Keywords:  Case report; Emery-Dreifuss muscular dystrophy; Exome sequencing; LMNA; Laminopathies

Mesh:

Substances:

Year:  2022        PMID: 36253810      PMCID: PMC9575219          DOI: 10.1186/s12887-022-03662-y

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.567


Background

Emery-Dreifuss Muscular Dystrophy (EDMD) (MIM 310,300 and 310,200) is a rare genetic muscular disease with an estimated incidence of 1–9 in 1,000,000 worldwide [1]. It resembles the most common muscular dystrophy, i.e., dystrophinopathy (Duchenne and Becker muscular dystrophy/ DMD and BMD). EDMD has three patterns of inheritance: X-linked recessive, autosomal recessive, and autosomal dominant [2]. Characteristic of EDMD is the presence of contracture in the neck, elbow, and heels in the patient or their relatives [3]. Mutation of the Lamin A (LMNA) gene that encodes lamin A/C protein, which causes EDMD, also causes a wide range of other diseases [4]. Thus, the overlapping genotype and phenotype similarities with other muscular dystrophies present diagnostic challenges. A precise diagnosis of EDMD is vital because the disease is associated with life-threatening cardiac conditions. Patients have clinical variabilities in disease progression, life expectancies and prognoses. Hence genetic counselling is essential for affected families once the disease has been diagnosed conclusively.

Case presentation

A 2 year-10-month-old male boy of Javanese descent presented to Universitas Gadjah Mada Academic Hospital with weakness of the lower limbs. The boy had an unremarkable birth history from nonconsanguineous parents (Fig. 1). There was no cognitive impairment, no seizure, visual or auditory impairment, and no bowel or bladder dysfunction. He walked at 12 months. Other developmental milestones were also unremarkable. He was vaccinated for age-appropriate immunizations according to the national immunization program guidelines.
Fig. 1

Pedigree of family showing EDMD status of each member. Shaded: affected EDMD

Pedigree of family showing EDMD status of each member. Shaded: affected EDMD The patient was conscious and afebrile on physical examination with no tachycardia or facial dysmorphic features. There was weakness in the proximal of the upper limbs and distal in the lower limbs. Facial weakness was not detected. No obvious calf pseudohypertrophy and no ankle joint contracture were observed (Fig. 2a). Follow-up at six years old, the patient presented wasting in the upper arm, Achilles contracture, and limitation of neck flexor because of neck contractures (Fig. 2b). Muscle strength examination was 4/5 on the upper and 4/5 on the lower limbs, with no cervical weakness. Swaying movements were present on walking. No toe walking was observed. The sensitivity of all digits was intact. Tendon and cutaneous reflexes were normal. He could walk without support, and the Gower sign was positive. The cardiorespiratory examination was unremarkable. No medical treatment had been given.
Fig. 2

A At age 2-year-10-month-old, elbow contractures were not evident, and no profound pseudohypertrophy of the calf and ankle joint contracture in the patient. B At age 6-year-old, the patient presented wasting, especially in the upper arm and Achilles contractures

A At age 2-year-10-month-old, elbow contractures were not evident, and no profound pseudohypertrophy of the calf and ankle joint contracture in the patient. B At age 6-year-old, the patient presented wasting, especially in the upper arm and Achilles contractures Laboratory examinations showed an increased creatine kinase (CK) level of 2485 UI/L, increased LDH level at 1078 U/L, haemoglobin count of 11.6 g/dl, white blood cell count of 9200 cells/μL and normal transaminase level. ECG showed no abnormality of conduction with normal p waves. Echocardiography showed normal structure and function of the heart. Significantly, the patient had no cardiac symptoms at this point. Investigation revealed that was no family history of members except for the father. History taking revealed the father presented with motoric disturbances and was diagnosed with acute flaccid paralysis at eight years old. He started toe walking and could not raise his hands against gravity since he was eight years of age, and there was no history of fever. At the time of the clinical presentation, he was easily exhausted and had difficulty climbing stairs. No shortness of breath and no swelling of the feet were found. On physical examination, there was no facial weakness. He could not bend his neck downwards nor sidewards. He had profound contractures of the elbow and heels (Fig. 3). Muscle wasting and weakness were found in scapulohumeroperoneal regions, with no contractures of fingers. He had decreased physiological reflex and no pathological reflex. Lordosis and scoliosis were detected. He has swaying and tiptoeing in his walk. He could ride a motorcycle by himself and was capable of performing his normal occupation. The father had increased CK level at 518 UI/L, but other blood results were within normal limits. Based on the clinical features, we suspected this was a case of EDMD with a differential diagnosis of limb-girdle muscular dystrophy. No NCS-EMG and MRI findings were available of the patient and the father as they did not consent to these procedures.
Fig. 3

Contractures of the Achilles (toe walking), contractures of the elbow, and atrophy of the scapulohumeral region. The rigidity of the neck was observed in the father

Contractures of the Achilles (toe walking), contractures of the elbow, and atrophy of the scapulohumeral region. The rigidity of the neck was observed in the father Exome sequencing was carried out on Illumina Hiseq 4000 platform (Illumina, San Diego, CA) at a mean read depth of 100x. Genomic DNA libraries were prepared by Agilent SureSelect Human All Exon V5 Kit (Agilent Technologies, Santa Clara, CA) following the manufacturer's protocol and sequenced through our laboratory at the National University of Singapore [4]; heterozygous variant involving a C to T transition in exon 7 of the LMNA gene (NM_170707: c.C1357T) was found (Fig. 4a). This variant leads to a missense mutation, Arg453Trp (R453W), that was previously reported to cause Autosomal Dominant EDMD. This variant was validated by Sanger sequencing in the patient. Targeted screening of this variant showed presence in the father, confirming this as a familial mutation (Fig. 4b). The variant was also classified as pathogenic based on the ACMG curation guidelines.
Fig. 4

a The genetic features reported in EDMD patients. The R453W mutations are located in the tail region, the Ig-like fold of the Lamin A/C proteins. b Sanger sequencing confirmation of the son and the father R453W (NM_170707: c.C1357T: NP_733821: p.Arg453Trp) mutation

a The genetic features reported in EDMD patients. The R453W mutations are located in the tail region, the Ig-like fold of the Lamin A/C proteins. b Sanger sequencing confirmation of the son and the father R453W (NM_170707: c.C1357T: NP_733821: p.Arg453Trp) mutation Knowing the EDMD phenotypes, we further examine the cardiac function of the father. Electrocardiography showed bradycardia with a heart rate of 40–50 bpm and total atrioventricular block with atrial fibrillation (Fig. 5). Echocardiography showed hypokinetic and dilatation of heart muscles, also thrombus suspicion in the left ventricle. Sinus node dysfunction was suspected; thus, atrioventricular block medication was administered. The cardiologist planned for urgent permanent pacemaker placement and further management of cardiomyopathy.
Fig. 5

Electrocardiography result showing total atrioventricular block with atrial fibrillation

Electrocardiography result showing total atrioventricular block with atrial fibrillation

Discussion and conclusion

Although initially grouped together with the other X-linked muscular dystrophies, most notably the dystrophinopathies forms, EDMD has become accepted as a separate and distinctive type after a thorough clinical evaluation of patients. A triad of presentations characterizes the disease course. The first two characteristic features are the weakness of the proximal muscle in childhood which initially affects the lower extremities, along with elbow flexion contractures and shortening of the Achilles tendon, consequently generating toe walking. Adults with EDMD manifest a waddling gait, lordotic stance and absence of the deep tendon reflexes. The third characteristic consists of arrhythmias, ranging from junctional rhythm (atrial standstill) to atrial fibrillation and even sudden cardiac death [5]. The serum CK level among the affected family members is also increased, although not in the similar range as in DMD or BMD. Other critical differences compared to DMD/BMD are the absence of developmental delay or the calf pseudohypertrophy. In 1966, this disease entity was differentiated and is currently known as X-linked EDMD [6]. EDMD creates a diagnostic challenge due to its similarities in the clinical presentation and laboratory findings with other muscular dystrophies. However, early diagnosis is crucial to prevent early mortality and morbidity from cardiac complications and muscular contractures. It is also essential to provide genetic screening for family members of the patients to determine risk. In neuromuscular disorder, a nerve conduction study with electromyography is essential to determine which structure is involved. As contracture or spasticity with weakness can be part of an upper motor neuron involvement, an MRI to rule out a central affection or an NCS-EMG with a myopathic pattern to support EDMD may be necessary to support their diagnosis [7]. Moreover, because the father had acute flaccid paralysis since he was eight years old, it is suggested that Charcot Marie Tooth (CMT) should be ruled out by NCS-EMG as some of CMT's variants were thought to be due to LMNA gene mutation. However, as we did not have data on NCS-EMG and MRI of the father of the case index, molecular analysis was performed to resolve the diagnosis for this case. EDMD has three main genetic patterns: X-linked recessive, autosomal dominant, and autosomal recessive, with the X-linked EDMD arising from emerin gene chromosome mutation (Xq28) being the most common. Autosomal recessive inheritance is extremely rare [8]. The emerin protein is located in the inner nuclear membrane of body cells, predominantly in skeletal and cardiac muscles. Mutation in the emerin gene causes premature termination in mRNA translation, disrupting protein synthesis and eventually nuclear functioning [9]. The autosomal dominant and recessive patterns of EDMD are known to be caused by mutations of the Lamin A/C genes (LMNA) gene on 1q21.2-q21.3. This mutation contributes to the disorder of cardiac and skeletal muscles. Lamin A/C proteins configure the inner nuclear membrane, which plays a significant role in mechanically stabilizing the nuclear envelope and cell signalling. Lamin A/C gene has 12 exons that produce at least four types of RNA via alternate splicing, including lamins A, Aδ10, C and C2. Lamin A and C are intermediate filament proteins. Their defects in the nuclear cells’ mechanical integrity cause disruption in the regulation of tissue-selective transcription alterations and defects in cell proliferation. From the genetic aspect, two hotspot mutations of LMNA have been reported: (1) Arg453Trp/R453W, consistently identified in EDMD, and (2) Arg482Trp/Gln/Leu(R482W/Q/L), consistently identified in patients presenting with partial lipodystrophy (FPLD). Mutations leading to striated muscle laminopathy (EDMD/LGMD1B/DCM-CD) are distributed all along the LMNA gene [10] (Fig. 4). As one of the most frequent mutations that are responsible for 16% of AD-EDMD cases, the exchange of arginine 453 by tryptophan (R453W) causes an abnormal nuclear phenotype [11, 12]. Therefore, this mutation is not uncommon. The R453W is a hot spot mutation previously associated with, and some phenotypes reported can be seen in Table 1.
Table 1

Phenotype presentations of EDMD that are reported to be associated with R453W

Age (y.o)SexOnset (Age)Inheri-tancePhenotypeCardiacRef
8F2yDe NovoAnkle contractureSinus arrhythmiaFan et al. [13]
4M2yDe NovoAnkle contractureNormal

Fan et al

[13]

14F4yDe NovoAnkle contracture, scoliosisSinus tachycardia

Fan et al

[13]

8M2yDe NovoElbow & ankle contracturesNormal

Fan et al

[13]

54FN/AN/AMuscle weakness and contractures

Dilated cardiomyopathy,

conduction disease

Bernasconi et al. [14]
21FN/AN/AMuscle weakness and contractures

Dilated cardiomyopathy,

conduction disease

Bernasconi et al. [14]
4M2yDe Novo

Proximal lower limb

weakness, both sides of ankle contractures

NormalLin et al. [14]
14F4yDe Novo

Proximal and distal

lower limb weakness. spine and both sides

of ankle contractures

Tachycardia, ultrasonic

cardiogram is normal

Lin et al. [15]
3F1yDe NovoLGMD, proximal lower limb weakness, both sides of ankle contracturesNormalLin et al. [15]
29M4yDe NovoWeakness in both legs, slow gait, ankle contracture, stiff neck, scoliosisAV block ILee et al. [16]
46MN/ADe NovoWasting and weakness of the proximal muscles, mild Achilles and elbow contractures, slight spine rigidity, lumbar hyperlordosisAV block III, AFib, SVT, Hypokinesia of IVS and anterior wall of LV, EF 15%, pacemakerMadej-Pilarczyk et al. [8]
36MN/ADe NovoContracture, spine rigidity

SVEB, SVT, VEB,

AV Block 1, ICD

Niebroj-Dobosz et al. [16]
44MN/AADContracture, spine rigidityAV Block 1,2,3, atrial standstill, nsVT, EF 36%, Pacemaker, ICDNiebroj-Dobosz et al. [17]
21FN/AADContracture, spine rigiditySVEB, SVT, ICDNiebroj-Dobosz et al.[17]
34M8yAD

Slowly progressive humero-peroneal muscular weakness. Rigid spine,

elbow and Achilles contractures

AV Block III; pacemaker at age 31; died at age 34 of heart failure;Meinke et al. [18]
37N/AN/AN/ALGMD, contracturesAfibMagagnotti et al. [18]
24MN/AADMild proximal weakness. Neck and heel cord contracturesEchocardiogram shows mildly enlarged left atrium and ventricle, mild global hypokinesis and reduced systolic function, estimated LVEF 45%Scharner et al. [19]
36MN/AN/AEDMD phenotypeFirst degree heart blockScharner et al. [19]
32MN/ADe NovoLimb-girdle, proximal, upper, distal lower muscle. Neck, elbow, ankle, knee contracturesBeta blockers at age 22, pacemaker at age 32Scharner et al. [19]
19M4yDe NovoLimb-girdle, proximal, upper, distal lower muscle. Neck, elbow, ankle contracturesNormalScharner et al. [19]
28F6yADLeg weakness (footdrop like gait). Elbow contractureEMG-diffuse myopathic process; cardiac involvementScharner et al. [19]
7M3yDe NovoLGMD, proximal lower extremity weakness, hip contracturesNormalScharner et al. [19]
32N/A4yDe NovoNo loss of ambulationN/ADeconinck et al. [20]
42N/A2yDe NovoLoss of ambulationN/ADeconinck et al. [20]
27N/A1yADNo loss of ambulationN/ADeconinck et al. [20]
4F2yADProximal limb muscle weakness, lordosis, calf hypertrophyNormalPark et al. [21]
N/AF10yADGeneralized muscle atrophy, spine rigidity, and spine, elbow, knee, ankle contracturesSVEB, SVTNiebroj-Dobosz et al. [22]
1 patientN/AN/AN/AProximal limb weakness without joint contracture, LGMD 1BCardiomyopathy with conduction defect in 34 yo patientAstejada et al. [23]
5 patientsN/AN/AN/A, ADJoint contractures. 2 patients have rigid spine syndrome. 1 patient has humeroperoneal muscle involvement with Achilles and elbows contractures, and hind neckAstejada et al. [23]
47FN/AADN/AAfib, ICDGolzio [24]
49M6yDe novoElbows and achilles contractures, rigid spine

Afib with

appropriately

functioning VVIR, Pacemaker

Sanna et al. [25]
16NAN/AN/AShoulder, hip, elbow, ankle, rigid spine contracturesNoneVytopil, et al.[26]
10NAN/AADRigid spineNoneVytopil, et al. [26]
46NAN/AN/ARigid spine, axial and proximal myopathiesConduction defects, pacemakerVytopil, et al. [26]
15F2yADProximal weakness. elbow, ankle contractures, mild neck stiff, rigid spineNormalColomer et al. [27]
12F2yADProximal weakness. elbow, ankle contractures, slight neck stiff, rigid spineNormalColomer et al. [27]
46F7yDe novoProximal weakness. elbow, ankle contractures, stiff neck rigid spine, wheelchair bound 44 yearsAV Block 26 y, pacemaker 31 yColomer et al. [27]
38MChildhoodADLimb girdle, upper, proximal, distal, lower muscle weakness. elbow and neck contracturesPacemakerBower et al. [28]
33MN/AADMuscle weakness, distal wasting, rigid spine, Achilles contractures and sometimes elbowsArrythmiaSewry, et al. [29]
35MN/AADArrythmiaSewry, et al. [29]
10 monthsMN/AADNormalSewry, et al. [29]
17MN/AADVentricular dysfunctionSewry, et al. [29]
19N/A3yDe NovoBoth arms wasting, stiff neck, elbow, hip, Achilles contracturesArrythmia, ventricular dysfunctionBonne, et al. [30]
33N/A8yDe NovoHumeroperoneal wasting, elbow, hip, Achilles contractures, stiff neck, rigid spine, kyphosisPacemakerBonne, et al. [30]
39M4yADMild proximal wasting, elbow, hip, Achilles contractures, stiff neck, rigid spine, scoliosisArrhythmia, normal echocardiographyBonne, et al. [30]
40M5yADProximal wasting, scapular winging, elbow, hip, Achilles contractures, stiff neck, rigid spine, scoliosisArrhythmia normal echocardiographyBonne, et al. [30]
9M3yADScapuloperoneal wasting, elbow, Achilles contractures, stiff neck, rigid spineNormalBonne, et al. [30]
7F4yADScapuloperoneal wasting, elbow, achilles contractures, stiff neck, rigid spineNormalBonne, et al. [30]
49MN/ADe NovoAtypical EMDPacemaker, Restrictive cardiomyopathy, died et causa cardiac arrestDi Barletta et al. [31]
39MN/AX-linkedX-EMD or Rigid Spine SyndromePacemakerDi Barletta et al. [31]
42MN/AX-linkedX-EMD or Rigid Spine SyndromeTachyarrhythmia and AV blockDi Barletta et al. [31]
21MN/AX-linkedX-EMDNoneDi Barletta et al. [31]
Phenotype presentations of EDMD that are reported to be associated with R453W Fan et al [13] Fan et al [13] Fan et al [13] Dilated cardiomyopathy, conduction disease Dilated cardiomyopathy, conduction disease Proximal lower limb weakness, both sides of ankle contractures Proximal and distal lower limb weakness. spine and both sides of ankle contractures Tachycardia, ultrasonic cardiogram is normal SVEB, SVT, VEB, AV Block 1, ICD Slowly progressive humero-peroneal muscular weakness. Rigid spine, elbow and Achilles contractures Afib with appropriately functioning VVIR, Pacemaker AD-EDMD has been reported with a broader clinical spectrum and higher frequency of de novo mutations than the X-linked form. Later and mild involvement of contracture in LGMD1B, which were re-classified as EDMD2, can contribute to its delayed diagnosis [32]. Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy in childhood. For discriminating EDMD from DMD patients, DMD children will have the following features: (a) delay in the acquisition of walking, which usually happens between 16 and 18 months; (b) early pseudohypertrophy of calves; (c) no elbow retractions; (d) CK values up to 100 times the maximum normal value; and (e) increased values of transaminases, which are never observed in patients with EDMD from either emerin or lamin A/C gene defects [33]. Moreover, the neurological examination of the father highlighted both muscular and cardiac characteristics making possible the suspicion of EDMD in our patient. In Indonesia, this is the second case of EDMD reported [14]. Moreover, our case is the first muscular dystrophy report from Indonesia using the whole-exome sequencing approach showing the utility of this approach together with clinical manifestation and usual diagnostic tests for establishing a diagnosis. However, it should be noted that many institutions worldwide do not have access to genetic testing. Although rare, there could be under-reporting of such cases due to a lack of precise molecular diagnosis because of clinical heterogeneity of this disease. This study highlights the importance of comprehensive genetic screening together with clinical features and usual diagnostic tests to further investigate suspicious cases that could resemble some form of DMD. Most the EDMD cases are sporadic cases. Therefore, presenting the same symptoms in two family members is unusual. Early presentation of EDMD in a boy would be easily mistaken as DMD. EDMD can be inherited by an X-linked pattern, which further shows similarity with DMD. Furthermore, precise diagnosis is essential, as attested in this case, where severe cardiac involvement in the father could be detected and treated earlier. We report a mutation in the LMNA gene underlying an autosomal dominant form of EDMD. EDMD phenotypes resemble the more common form of muscular dystrophy, i.e. dystrophinopathies (DMD/BMD), and may also be inherited in an x-linked inheritance pattern. EDMD should be considered when diagnosing a child with a clinical suspicion of DMD. Early diagnosis, intervention, targeted management, and counselling are crucial to increasing the health and life quality of EDMD patients.
  32 in total

Review 1.  Emery-Dreifuss muscular dystrophy - a 40 year retrospective.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  2000-06       Impact factor: 4.296

Review 2.  108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands.

Authors:  Gisèle Bonne; Rabah Ben Yaou; Christophe Béroud; Giuseppe Boriani; Sue Brown; Marianne de Visser; Denis Duboc; Juliet Ellis; Irena Hausmanowa-Petrusewicz; Giovanna Lattanzi; Luciano Merlini; Glenn Morris; Francesco Muntoni; Grzegorz Opolski; Yigal M Pinto; Federica Sangiuolo; Daniela Toniolo; Richard Trembath; Jop H van Berlo; Anneke J van der Kooi; Manfred Wehnert
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

3.  Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern.

Authors:  N Deconinck; E Dion; R Ben Yaou; A Ferreiro; B Eymard; L Briñas; C Payan; T Voit; P Guicheney; P Richard; V Allamand; G Bonne; T Stojkovic
Journal:  Neuromuscul Disord       Date:  2010-06-23       Impact factor: 4.296

4.  A novel de novo mutation in Lamin A/C gene in Emery Dreifuss Muscular Dystrophy patient with atrial paralysis.

Authors:  Chaerul Achmad; Almira Zada; Mardlatillah Affani; Mohammad Iqbal; Erwan Martanto; Augustine Purnomowati; Toni M Aprami
Journal:  J Atr Fibrillation       Date:  2017-04-30

5.  Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations.

Authors:  C A Sewry; S C Brown; E Mercuri; G Bonne; L Feng; G Camici; G E Morris; F Muntoni
Journal:  Neuropathol Appl Neurobiol       Date:  2001-08       Impact factor: 8.090

6.  Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy.

Authors:  E Mercuri; S Counsell; J Allsop; H Jungbluth; M Kinali; G Bonne; K Schwartz; G Bydder; V Dubowitz; F Muntoni
Journal:  Neuropediatrics       Date:  2002-02       Impact factor: 1.947

Review 7.  Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.

Authors:  M N Astejada; K Goto; A Nagano; S Ura; S Noguchi; I Nonaka; I Nishino; Y K Hayashi
Journal:  Acta Myol       Date:  2007-12

8.  Clinical spectrum and genetic variations of LMNA-related muscular dystrophies in a large cohort of Chinese patients.

Authors:  Yanbin Fan; Dandan Tan; Danyu Song; Xu Zhang; Xingzhi Chang; Zhaoxia Wang; Cheng Zhang; Sophelia Hoi-Shan Chan; Qixi Wu; Liwen Wu; Shuang Wang; Hui Yan; Lin Ge; Haipo Yang; Bing Mao; Carsten Bönnemann; Jingying Liu; Suxia Wang; Yun Yuan; Xiru Wu; Hong Zhang; Hui Xiong
Journal:  J Med Genet       Date:  2020-06-22       Impact factor: 6.318

9.  Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes.

Authors:  Pia Bernasconi; Nicola Carboni; Giulia Ricci; Gabriele Siciliano; Luisa Politano; Lorenzo Maggi; Tiziana Mongini; Liliana Vercelli; Carmelo Rodolico; Elena Biagini; Giuseppe Boriani; Lucia Ruggiero; Lucio Santoro; Elisa Schena; Sabino Prencipe; Camilla Evangelisti; Elena Pegoraro; Lucia Morandi; Marta Columbaro; Chiara Lanzuolo; Patrizia Sabatelli; Paola Cavalcante; Cristina Cappelletti; Gisèle Bonne; Antoine Muchir; Giovanna Lattanzi
Journal:  Nucleus       Date:  2018-01-01       Impact factor: 4.197

10.  Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy.

Authors:  Hui-Ting Lin; Xiao Liu; Wei Zhang; Jing Liu; Yue-Huan Zuo; Jiang-Xi Xiao; Ying Zhu; Yun Yuan; Zhao-Xia Wang
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.